ArticleBreast cancer (Tokyo, Japan)2021

TP53 signature diagnostic system using multiplex reverse transcription-polymerase chain reaction system enables prediction of prognosis of breast cancer patients.

Shin Takahashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.